The first demonstration of the potential involvement of AIIt in cancer was our observation, in 2003, that knockdown of S100A10 in HT1080 cells resulted in concomitant decreases in cellular plasmin production, extracellular matrix degradation, and cellular invasiveness [186]. This evidence concerns the gene S100A10 and cancer.